Pay in 4 interest-free payments of $11.25 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
enzymes and transporters
is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway
PubMed PMID: 15860572
CPI-637 inhibits MYC expression in AMO-1 cells (EC50 = 0
The discovery of the benzhydroxamate MEK inhibitors CI-1040 and PD 0325901
KPT-330 - CAS# 1393477-72-9 009 enzymes and transportersKPT 330, CAS No. 1393477 72 9, is an orally bioavailable, potent and selective XPO1 CRM1 Inhibitor. KPT 330 is effective in acquired resistance to ibrutinib and synergizes with ibrutinib in chronic lymphocytic leukemia. KPT 330 potentiates the antitumor activity of gemcitabine in human pancreatic cancer through inhibition of tumor growth, depletion of the antiapoptotic proteins, and induction of apoptosis. KPT 330 has strong activity against primary
US$ 72.00
US$ 125.00
US$ 65.00
US$ 65.00
US$ 75.00
US$ 48.00
US$ 36.00
US$ 38.00
US$ 48.00
US$ 38.00
US$ 137.50